Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Chung Yin Kong"'
Autor:
Minal S. Kale, MD, MPH, Keith Sigel, MD, PhD, Arushi Arora, MPH, Bart S. Ferket, MD, PhD, Juan Wisnivesky, MD, DrPh, Chung Yin Kong, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 3, Pp 100635- (2024)
Introduction: Individuals with a history of smoking and a high risk of lung cancer often have a high prevalence of smoking-related comorbidities. The presence of these comorbidities might alter the benefit-to-harm ratio of lung cancer screening by in
Externí odkaz:
https://doaj.org/article/81178f440074456ba2b85aac46a2bfc9
Autor:
Amanda Leiter, Christian Stephens, Grace Mhango, Chung Yin Kong, Keith Sigel, Jenny J. Lin, Emily J. Gallagher, Derek LeRoith, Juan P. Wisnivesky
Publikováno v:
Heliyon, Vol 9, Iss 7, Pp e17969- (2023)
Background: Diabetes is a common comorbidity in patients with early-stage non-small cell lung cancer (NSCLC), a growing population due to increased LC screening. However, it is unknown if diabetes is associated with less aggressive NSCLC treatment an
Externí odkaz:
https://doaj.org/article/a8096ff8ffb942129483f1474d71756b
Autor:
Keith Sigel, Rafael E. de laHoz, Steven B. Markowitz, Chung Yin Kong, Kimberly Stone, Andrew C. Todd, Juan P. Wisnivesky
Publikováno v:
Cancer Medicine, Vol 11, Iss 16, Pp 3136-3144 (2022)
Abstract Background Many World Trade Center disaster (WTC) rescue and recovery workers (WTC RRWV) were exposed to toxic inhalable particles. The impact of WTC exposures on lung cancer risk is unclear. Methods Data from the WTC Health Program General
Externí odkaz:
https://doaj.org/article/6c62b5e4abce4f84af9b1dc484a46942
Autor:
Myles A. Ingram, Brianna N. Lauren, Yoanna Pumpalova, Jiheum Park, Francesca Lim, Susan E. Bates, Fay Kastrinos, Gulam A. Manji, Chung Yin Kong, Chin Hur
Publikováno v:
Cancer Reports, Vol 5, Iss 9, Pp n/a-n/a (2022)
Abstract Background The 2020 National Comprehensive Cancer Network guidelines recommend neoadjuvant FOLFIRINOX or neoadjuvant gemcitabine plus nab‐paclitaxel (G‐nP) for borderline resectable/locally advanced pancreatic ductal adenocarcinoma (BR/L
Externí odkaz:
https://doaj.org/article/e421dd6448d6472fab80e7690d3e02c8
Autor:
Hsi-Lan Huang, Chi Yan Leung, Eiko Saito, Kota Katanoda, Chin Hur, Chung Yin Kong, Shuhei Nomura, Kenji Shibuya
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract Background A national endoscopic screening program for gastric cancer was rolled out in Japan in 2015. We used a microsimulation model to estimate the cost-effectiveness of current screening guidelines and alternative screening strategies in
Externí odkaz:
https://doaj.org/article/05cb02e75ea64c9eb92673a84e85bb17
Autor:
Amanda Leiter, Chung Yin Kong, Michael K Gould, Minal S Kale, Rajwanth R Veluswamy, Cardinale B Smith, Grace Mhango, Brian Z Huang, Juan P Wisnivesky, Keith Sigel
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0263911 (2022)
BackgroundRandomized controlled trials (RCTs) have demonstrated a survival benefit for adjuvant platinum-based chemotherapy after resection of locoregional non-small cell lung cancer (NSCLC). The relative benefits and harms and optimal approach to tr
Externí odkaz:
https://doaj.org/article/815904f40e294408a0e4e8bd05458a2d
Publikováno v:
Cancer Medicine, Vol 8, Iss 11, Pp 5158-5172 (2019)
Abstract Background Detailed cost estimates are not widely available for esophageal cancer. Our study estimates phase‐specific costs for esophageal cancer by age, year, histology, stage, and treatment for older patients in the United States and com
Externí odkaz:
https://doaj.org/article/ddcb1d7b9d4f46a5a29a7302ad56649f
Autor:
Keith Sigel, Chung Yin Kong, Sadiq Rehmani, Susan Bates, Michael Gould, Kimberly Stone, Minal Kale, Yeun-Hee Park, Kristina Crothers, Faiz Bhora, Juan Wisnivesky
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248067 (2021)
BackgroundVeterans are at increased risk of lung cancer and many have comorbidities such as chronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD). We used simulation modeling to assess projected outcomes associated with diffe
Externí odkaz:
https://doaj.org/article/f50e78f60eae4c43916925675459dd8a
Autor:
Kevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, Summer S Han, Chung Yin Kong, Sylvia K Plevritis, Eric J Feuer, Harry J de Koning, Ewout W Steyerberg, Rafael Meza
Publikováno v:
PLoS Medicine, Vol 17, Iss 9, p e1003403 (2020)
[This corrects the article DOI: 10.1371/journal.pmed.1002277.].
Externí odkaz:
https://doaj.org/article/6aff612e300a487e9212ed02c7a39e6a
Autor:
Steven D Criss, Lauren Palazzo, Tina R Watson, Adelle M Paquette, Keith Sigel, Juan Wisnivesky, Chung Yin Kong
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228288 (2020)
ObjectivesWhile previous cost-effectiveness studies on pembrolizumab in stage IV non-small cell lung cancer (NSCLC) have found these regimens to be cost-effective, their reliance on randomized controlled trial (RCT) data with strict inclusion criteri
Externí odkaz:
https://doaj.org/article/7aac7c6ffd16408b813b1c8a9485fc43